Leucadia National - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
Leucadia National ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$73,441,346
+15.2%
2,729,147
+28.9%
0.66%
+15.6%
Q2 2023$63,753,920
+61.9%
2,117,367
+73.9%
0.57%
+79.0%
Q1 2023$39,379,655
-9.6%
1,217,300
-19.9%
0.32%
+5.3%
Q4 2022$43,563,200
+8042.7%
1,520,000
+6270.5%
0.30%
+471.7%
Q1 2019$535,000
-98.4%
23,860
-98.1%
0.05%
-98.1%
Q3 2016$33,682,0001,274,4002.76%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders